CCSVI Info Night (1/28/11)
Guests (in order of appearance)
Marie Rhodes, RN has been living with MS since 1991. She was the
second person treated at Stanford in May of 2009 for CCSVI and has
written a book due out in April of 2011 called CCSVI as the Cause of MS:
The Science Behind the Controversial Theory. She is active in the CCSVI
movement to generate funds for research of CCSVI by volunteering for
the CCSVI Alliance patient board and also by donating 10% of her
proceeds from the book to their 501(3)(c) charity. It is currently available
for pre-order on Amazon.com.
Speaking on “Multiple Sclerosis as a vascular disease:
The background and history.”
Eric Feigenbutz, BS, RVT is President and Co-Founder of
Arizona Doppler Specialists, accredited mobile vascular lab in Arizona.
He obtained his Bachelor of Science degree with a major in Medical
Imaging Technology-Vascular option from Oregon Institute of
Technology. His passion for CCSVI started in early 2010 when a MS
patient approached Saguaro Surgical (see below) with a substantial
amount of information about Dr. Paolo Zamboni’s CCSVI hypothesis.
Just a few months later, he was specially trained in the Zamboni
Protocol for detecting CCSVI at the Buffalo Neuroimaging Analysis
Center (BNAC) in New York.
Michael Lavor, MD, FACS is a board-certified surgeon with
extensive training and experience with endovascular surgery. He is a
Fellow of the American College of Surgeons, Director of Vascular
Services at Tucson Medical Center, Clinical Associate Professor at the
University of Arizona Medical Center Department of Surgery, past
President of the Rocky Mountain Vascular Surgical Society and past
Chief of Staff at Eldorado Hospital. He graduated from the University of
New Mexico Medical School and completed his residency through the
University of Illinois Metro Group Hospitals. He set up one of the first
vascular labs in the southwest and has been in private practice since
1991. He also spent twelve years as a Navy Corpsman and is currently a
Commander in the Naval Reserves. He and his partner, Dr Matthew
Namanny, have been treating CCSVI at Saguaro Surgical for close to
Speaking on “The Relationship between Zamboni protocol Doppler
ultrasound testing, venogram and venoplasty.’
James F. McGuckin, MD is Medical Director of The Philadelphia
Vascular Institute and Founder and CEO of Vascular Access Centers,
which specializes in high level peripheral arterial work, limb salvage, and
venous disorders, including CCSVI treatment and recanalization of
central venous occlusion. He graduated from the University of Notre
Dame in 1983, double majoring in Mechanical Engineering and Pre-
Medical. He furthered his medical training at Hahnemann University in
1987. Dr. McGuckin received his Masters in Bioengineering at the
University of Pennsylvania in 1990, and completed a fellowship in
Interventional Radiology at the University of Pennsylvania in 1996. Dr.
McGuckin is widely published and is an invited presenter at conferences
nationally and internationally.
The patient experience, including what to expect during
and after venoplasty. Also, guest speaker and patient Steven Lundin.
David R. Hubbard, MD is a board-certified Neurologist and
Chairman of the Hubbard Foundation in San Diego, CA, sponsor of 3
IRB approved studies on CCSVI. He is also a Research Professor at the
California School of Professional Psychology, Alliant International
University, and Adjunct Professor of Psychology, San Diego State
University. He majored in philosophy at Yale, received a Masters in
Counseling Psychology at Stanford, an MD at the University of
Connecticut and his neurology training at Albert Einstein College of
Medicine in New York, where he was chief resident. He is the treasurer
of the International Society for NeuroVascular Disease, of which Dr.
Paolo Zamboni is president. This March, Dr Hubbard will present the
findings from his fMRI study at the ISNVD conference in Ferrara,
Italy. He will present the testing, treatment and clinical outcomes for the
first 200 patients at the Hubbard Foundation CCSVI conference in May
Explanation of the Hubbard Foundation study on
CCSVI, preliminary results and the importance of data
collection and tracking.
Q & A
Unique opportunity to ask our guests questions.